Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer
Daniiar Dyikanov, A. V. Zaitsev, Т.В. Васильева, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 759-779.e12
Open Access | Times Cited: 20

Showing 20 citing articles:

Predictive circulating biomarkers of the response to anti‐PD‐1 immunotherapy in advanced HER2 negative breast cancer
Yuhan Wei, Hewei Ge, Yalong Qi, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 3
Open Access | Times Cited: 1
Technology and Future of Multi-Cancer Early Detection
Danny A. Milner, Jochen K. Lennerz
Life (2024) Vol. 14, Iss. 7, pp. 833-833
Open Access | Times Cited: 6
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Menglei Jin, Jun Fang, Jiakuan Peng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Metabolites and metabolic pathway reactions links to sensitization of immunotherapy in pan-cancer
Shaobo Yu, Yuzhen Gao, Feng Zhao, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200933-200933
Open Access
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Noor A. M. Bakker, Hannah Garner, Ewald van Dyk, et al.
npj Breast Cancer (2025) Vol. 11, Iss. 1
Open Access
Low-exhaustion peripheral circulating γδ T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study
Dongdong Zhang, Guichao Liu, Jinhui Ye, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Dynamic changes in peripheral blood immunophenotyping and its prognostic value in cervical cancer patients undergoing immune checkpoint blockade therapy
Wenjian Gong, Zhi Wang, Yongqiang Wei, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Peripheral blood biomarkers in monitoring treatment response in breast cancer patients
Andres A. Ocampo, Xiaopeng Sun, Justin M. Balko
Expert Review of Molecular Diagnostics (2025)
Closed Access
Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types
Eric V. Mastrolonardo, Pablo Llerena, Emma De Ravin, et al.
Cancer (2025) Vol. 131, Iss. 6
Open Access
Illuminating Immunity: A Systematic Review of Immune Cell Autofluorescence
Aline Knab, Caroline Giardina, Shane T. Grey, et al.
Journal of Biophotonics (2025)
Open Access
Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy
Verena Schweihofer, Christina Bruß, Stephan Seitz, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Precision Cancer Medicine 2.0—Oncology in the postgenomic era
Riccardo Masina, Carlos Caldas
Molecular Oncology (2024)
Open Access | Times Cited: 1
Absolute lymphocyte count predicts efficacy of palbociclib in patients with metastatic luminal breast cancer
Takayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Systems profiling reveals recurrently dysregulated cytokine signaling responses in ER+ breast cancer patients’ blood
Brian Orcutt-Jahns, Joao Rodrigues Lima, E. Lin, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Dysregulation of systemic immunity in colorectal cancer and its clinical applications as biomarkers and therapeutics
LI Chang-qin, Jian Li
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104543-104543
Closed Access | Times Cited: 1
Prognostic Modeling and Emerging Therapeutic Targets Unveiled through Single-Cell Sequencing in Esophageal Squamous Cell Carcinoma
B H Pan, Haochun Shi, Guangyao Shan, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38078-e38078
Open Access
Coupling of response biomarkers between tumor and peripheral blood in patients undergoing chemoimmunotherapy
Wee Loong Chin, Alistair Cook, Jonathan Chee, et al.
Cell Reports Medicine (2024), pp. 101882-101882
Open Access
An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
Kaiyi Li, Chang Liu, Chao Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Prognostic Modeling and Emerging Therapeutic Targets Unveiled Through Single-Cell Sequencing in Esophageal Squamous Cell Carcinoma
Binyang Pan, Haochun Shi, Guangyao Shan, et al.
(2024)
Closed Access
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
Ling Chen, Hongyu Tan, Ruixuan Geng, et al.
Thoracic Cancer (2024) Vol. 16, Iss. 1
Closed Access
Peripheral Circulating Blood Cells Deviation Based on Tumor Inflammatory Microenvironment Activity in Resected Upstaged Lung Adenocarcinomas
Alessandro Bonis, Francesca Lunardi, Giulia Pagliarini, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7597-7597
Open Access
Page 1

Scroll to top